부산대학교 도서관

To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.clindermatol.2009.02.006 Byline: Brett M. Coldiron (a), Scott Dinehart (b), Howard W. Rogers (c) Abstract: Malignant melanoma is a cutaneous malignancy characterized by high metastatic potential and an unpredictable course. Enormous amounts of research have been done into surgical and adjunctive therapies for melanoma. Given the regularity with which sentinel lymph node biopsy and completion lymph node dissection are performed at private and academic hospitals, it would seem that evidence supporting these procedures is not controversial. A growing body of studies, however, points to sentinel lymph node biopsy and completion lymph node dissection as ineffective treatment for malignant melanoma and necessitates a discussion of what constitutes standard of care. Author Affiliation: (a) Department of Dermatology, University of Cincinnati College of Medicine, 3024 Burnet Avenue, Cincinnati, OH 45219, USA (b) Department of Dermatology, University of Arkansas School of Medicine, 6901 Lile Drive, Little Rock, AR 72205, USA (c) Advanced Dermatology, LLC, 111 Salem Turnpike, Suite 7 Norwich, CT 06360, USA